Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Overcoming Obstacles in AAV Viral Vector Manufacturing
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Continuous processing optimization with smarter tools
Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific
Headline News
FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting
Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer
Jemperli achieves 76% complete response rate in Phase II rectal cancer trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L
Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022
Variability, Limits, and Other Considerations for the Next Generation of Pyrogen and Endotoxin Testing
Presented by Karen Zink McCullough, Owner, Principal Consultant at MMI Associates, Kevin L. Williams, Microbiological Test Development at bioMérieux, Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories, Veronika Wills, Manager, Technical Services at Associates of Cape Cod, Inc and Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza
02nd February 2023
Characterization of Residual Impurities in Gene Therapy Drug Products
Presented by Jessica Townsend, Senior Manager Analytical Development at bluebird bio and Eric S. Bishop, Vice President of Research & Development at Cygnus Technologies
26th January 2023
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
